Research ExplorerPublicationsCorrection to: Results of a randomized trial of treatment mo...

Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

Standard

Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial). / Wiegel, Thomas; Albers, Peter; Bartkowiak, Detlef; Bussar-Maatz, Roswitha; Härter, Martin; Kristiansen, Glen; Martus, Peter; Wellek, Stefan; Schmidberger, Heinz; Grozinger, Klaus; Renner, Peter; Schneider, Fried; Burmester, Martin; Stöckle, Michael.

2 p. 1 ed. 2021. (J CANCER RES CLIN).

Research output: Other contribution › Other › Research

Harvard

Wiegel, T, Albers, P, Bartkowiak, D, Bussar-Maatz, R, Härter, M, Kristiansen, G, Martus, P, Wellek, S, Schmidberger, H, Grozinger, K, Renner, P, Schneider, F, Burmester, M & Stöckle, M 2021, Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).. https://doi.org/10.1007/s00432-020-03497-z

APA

Wiegel, T., Albers, P., Bartkowiak, D., Bussar-Maatz, R., Härter, M., Kristiansen, G., Martus, P., Wellek, S., Schmidberger, H., Grozinger, K., Renner, P., Schneider, F., Burmester, M., & Stöckle, M. (2021, Jan). Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial). (1 ed.) https://doi.org/10.1007/s00432-020-03497-z

Vancouver

Wiegel T, Albers P, Bartkowiak D, Bussar-Maatz R, Härter M, Kristiansen G et al. Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial). 2021. 2 p. https://doi.org/10.1007/s00432-020-03497-z

Bibtex

@misc{f066af8bd23a4e088403cec7d7304e63,
title = "Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)",
author = "Thomas Wiegel and Peter Albers and Detlef Bartkowiak and Roswitha Bussar-Maatz and Martin H{\"a}rter and Glen Kristiansen and Peter Martus and Stefan Wellek and Heinz Schmidberger and Klaus Grozinger and Peter Renner and Fried Schneider and Martin Burmester and Michael St{\"o}ckle",
year = "2021",
month = jan,
doi = "10.1007/s00432-020-03497-z",
language = "English",
volume = "147",
series = "J CANCER RES CLIN",
publisher = "Springer",
edition = "1",
type = "Other",

}

RIS

TY - GEN

T1 - Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

AU - Wiegel, Thomas

AU - Albers, Peter

AU - Bartkowiak, Detlef

AU - Bussar-Maatz, Roswitha

AU - Härter, Martin

AU - Kristiansen, Glen

AU - Martus, Peter

AU - Wellek, Stefan

AU - Schmidberger, Heinz

AU - Grozinger, Klaus

AU - Renner, Peter

AU - Schneider, Fried

AU - Burmester, Martin

AU - Stöckle, Michael

PY - 2021/1

Y1 - 2021/1

U2 - 10.1007/s00432-020-03497-z

DO - 10.1007/s00432-020-03497-z

M3 - Other

C2 - 33346877

VL - 147

T3 - J CANCER RES CLIN

ER -